We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03324061
Recruitment Status : Completed
First Posted : October 27, 2017
Last Update Posted : June 3, 2021
Information provided by (Responsible Party):
Eagle Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 12, 2018
Actual Study Completion Date : July 12, 2018